|本期目录/Table of Contents|

[1]陈亚巍,孙新增,张 萍,等.非糖尿病SHPT血液透析患者行PTX+AT对钙磷代谢和胰岛素分泌的影响[J].天津医科大学学报,2018,24(06):532-535.
 CHEN Ya-wei,SUN Xin-zeng,ZHANG Ping,et al.Effects of parathyroidectomy with autotransplantation on calcium- phosphorus disorder and insulin secretion in non-diabetic uremic patients with SHPT[J].Journal of Tianjin Medical University,2018,24(06):532-535.
点击复制

非糖尿病SHPT血液透析患者行PTX+AT对钙磷代谢和胰岛素分泌的影响(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
24
期数:
2018年06期
页码:
532-535
栏目:
临床医学
出版日期:
2018-11-20

文章信息/Info

Title:
Effects of parathyroidectomy with autotransplantation on calcium- phosphorus disorder and insulin secretion in non-diabetic uremic patients with SHPT
作者:
陈亚巍孙新增张 萍陶新朝
(中国人民解放军第254医院肾脏内科,天津300142)
Author(s):
CHEN Ya-weiSUN Xin-zengZHANG PingTAO Xin-chao
(Department of Nephrology,Chinese PLA 254th Hospital,Tianjin 300142,China)
关键词:
维持性血液透析继发性甲状旁腺功能亢进甲状旁腺切除术胰岛素
Keywords:
maintenance hemodialysis secondary hyperparathyroidism total parathyroidectomy insulin
分类号:
R605
DOI:
-
文献标志码:
A
摘要:
目的:观察非糖尿病维持性血液透析(MHD)患者并发继发性甲状旁腺亢进(SHPT) 后行甲状旁腺全切术+前臂移植( PTX+AT)钙磷和糖代谢指标的变化。方法:回顾性分析84例MHD并发SHPT的临床资料,其中52例SHPT患者行PTX+AT手术治疗,32例行药物治疗,观察治疗前后全段甲状旁腺激素(iPTH)、血钙(Ca)、血磷(P)、血碱性磷酸酶(ALP)等指标的变化,以及患者空腹血糖、胰岛素水平变化。结果:PTX+AT术后,患者血Ca、P、iPTH和ALP水平明显降低,术后1周胰岛素水平开始明显升高,差异具有统计学意义(P<0.05);而药物治疗组1个月和3个月血P、iPTH明显降低,但6个月后恢复至治疗前水平,且ALP水平明显增高,血糖和胰岛素水平无显著性变化。结论: PTX+AT是治疗SHPT的有效手段,可明显降低血iPTH水平,调节钙磷代谢紊乱;同时可以增加胰岛素分泌。
Abstract:
Objective: To observe the effects of PTX+AT on calcium-phosphorus disorder and insulin secretion for non-diabetic uremic patients with SHPT. Methods:Eighty-four MHD with SHPT patients were enrolled, and their data were retrospectively analyzed. Fifty-two SHPT patients were treated with PTX+AT and thirty-two patients were treated with medicine. Serum intact parathyroid hormone (iPTH), calcium (Ca), phosphorus (P),alkaline phosphatase (ALP) and fasting insulin obtained preoperatively and postoperatively were collected and compared. Results: Serum iPTH, Ca, and P decreased significantly in postoperative period (P<0.05) and fasting insulin began to increase significantly in one week after the operation (P<0.05). After one month and three months of medical treatment, the level of iPTH and P decreased significantly.But after six months the effect disappeared, and ALP level increased significantly. The change of fasting glucose and insulin had was not statistically significant. Conclusion: PTX+AT can effectively decrease iPTH level and regulate the calcium-phosphorus disorder, so it is an effective operation for uremic patients with SHPT. It can also promote the secretion of insulin.

参考文献/References:


[1] Shoji T,Emoto M,Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients[J]. Nephron,2001,89(3):348
[2] Yun K J,Han K,Kim M K,et al. Insulin Resistance Distribution and Cut-Off Value in Koreans from the 2008-2010 Korean National Health and Nutrition Examination Survey[J]. PLoS One,2016,11(4):e0154593
[3] 张建荣,耿燕秋,张承英,等. 70例尿毒症继发性甲状旁腺亢进症行甲状旁腺全切术的疗效分析[J]. 中国血液净化,2014,13(9):617
[4] 卢建跃,孙新增,张霆. 慢性肾病合并甲状旁腺亢进的外科治疗[J]. 中国中西医结合外科杂志,2014,20(1):64
[5] Tominaga Y,Matsuoka S,Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease[J]. Ther Apher Dial,2005,9(1):44
[6] Niemczyk S,Szamotulska K,Giers K,et al. Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients[J]. Med Sci Monit,2013,19:592
[7] Bernardo A P,Oliveira J C,Santos O,et al. Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition,Peritoneal Transport,and Peritoneal Glucose Absorption[J]. Clin J Am Soc Nephrol, 2015,10(12):2205
[8] Johnson J A,Grande J P,Roche P C,et al. Immunohistochemical localization of 1,25 (OH)2D3 receptor and calbindin D28k in human and rat pancreas[J]. Am J Physiol,1994,267(3Pt1): E356
[9] Lu K C,Shieh S D,Lin S H,et al. Hyperparathyroidism,glucose tolerance and platelet intracellular free calcium in chronic renal failure[J]. QJMed,1994,87(6):359
[10] Bland R,Markovic D,Hills C E,et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets[J]. J Steroid Biochem Mol Biol,2004,89(1/5):121
[11] Maestro B,Davila N,Carranza M C,et al. Identification of a Vitamin D response element in human insulin receptor gene promoter[J]. J Steroid Biochem Mol Biol,2003,84(2/3): 223
[12] Bourlon P M,Billaudel B,Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas[J]. J Endocrinol,1999,160(1):87
[13] Mak R H. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia[J]. Kidney Int,1998,53(5):1353
[14] Liao M T,SungC C,Hung K C,et al. Insulin resistance in patients with chronic kidney disease[J]. J Biomed Biotechnol,2012,2012:691369
[15] 陈立立,刘超.钙通道对β细胞胰岛素分泌的调节作用[J]. 医学综述,2009,15(11):1620
[16] Mak R H,Turner C,Haycock G B,et al. Secondary hyperparathyroidism and glucose intolerance in children with uremia[J].Kidney Int Suppl,1983,16:S128
[17] Nikalji R,Bargman J M. Severe hypoglycemia with endogenous hyperinsulinemia in a nondiabetic hemodialysis patient following parathyroidectomy[J]. Nephrol Dial Transplant,2011,26(6):2050
[18] Akmal M,Massry S G,Goldstein D A,et al. Role of parathyroid hormone in the glucose intolerance of chronic renal failure[J]. J Clin Invest,1985,75(3):1037

相似文献/References:

[1]张瑞宁,魏 芳,王立华,等.碳酸镧治疗维持性血液透析高磷血症患者疗效观察[J].天津医科大学学报,2014,20(04):303.
[2]孟 甲,魏 芳,王立华,等.终末期肾病血液透析相关性腹水发生情况及其相关危险因素的探讨[J].天津医科大学学报,2017,23(02):112.

备注/Memo

备注/Memo:
作者简介 陈亚巍(1981-),主治医师,博士,研究方向:慢性肾脏病-矿物质和骨代谢异常(CKD-MBD)及其并发症,E-mail:tjcywei1981@163.com。
更新日期/Last Update: 2018-11-30